PNC Financial Services Group’s Sana Biotechnology SANA Stock Holding History
Bought
Maintained
Sold
Other funds holding SANA
FP
VCM
MG
IHAM
PNC Financial Services Group's SANA Position: Q1 2026 in Review
PNC Financial Services Group held its Sana Biotechnology (SANA) position steady in Q1 2026 at 12,043 shares worth $34.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3429.
PNC Financial Services Group first reported a position in SANA in Q1 2021 and has held it in 19 quarters since. The position peaked at $49K in Q4 2025. 202 funds tracked by Wall St. Rank hold SANA as of Q1 2026.
- PNC Financial Services Group held 12,043 shares of Sana Biotechnology worth $34.7K as of Q1 2026.
- PNC Financial Services Group left its Sana Biotechnology share count unchanged in Q1 2026.
- Sana Biotechnology made up ﹤0.01% of PNC Financial Services Group's portfolio in Q1 2026, its #3429 holding.
- PNC Financial Services Group first reported a position in Sana Biotechnology in Q1 2021 and has held it in 19 quarters since.
- PNC Financial Services Group's Sana Biotechnology position peaked at $49K in Q4 2025.
- 202 funds tracked by Wall St. Rank held Sana Biotechnology as of Q1 2026.
Based on PNC Financial Services Group's 13F filing for Q1 2026, filed 8 May 2026.